LaTisha Weaver is a clinical research budget and contract strategist specializing in study development across investigator-initiated trials (IITs) through Phase I–IV studies spanning multiple therapeutic areas, including oncology. With over eight years of experience, she brings a comprehensive understanding of how financial strategy directly impacts study feasibility, activation timelines, and site performance.

As the Founder of LDM Clinical Research Source, she works with independent sites, academic institutions, and research networks to design and negotiate budgets that reflect true operational cost and complexity. Her experience spans 100+ sponsors, CROs, SNOs/SMOs, and biotech/pharmaceutical organizations, giving her a cross-functional view of decision-making across the clinical research landscape.

LaTisha is the creator of the “Budget Justice” framework, a strategic model that challenges one-size-fits-all budgeting and promotes alignment between standardized principles and site-specific needs. Her work centers on ensuring that access to studies and fair compensation are not mutually exclusive, but foundational to sustainable clinical research.